Home
About
Overview
Sharing Data
ORCID
Help
History (108)
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease.
Illumination for worm tracking and behavioral imaging.
Using the Elixhauser risk adjustment model to predict outcomes among patients hospitalized in internal medicine at a large, tertiary-care hospital in Israel.
Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases.
See All 108 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases.
Lin C, Greenblatt MB, Gao G, Shim JH. Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases. Hum Gene Ther. 2024 05; 35(9-10):317-328.
View in:
PubMed
subject areas
Animals
Bone Diseases
Dependovirus
Gene Editing
Gene Transfer Techniques
Genetic Therapy
Genetic Vectors
Humans
authors with profiles
Jae-Hyuck Shim PhD
Guangping Gao PhD